Previous 10 | Next 10 |
Nes Ziona, Israel, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced positive interim efficacy data from the Company’s ongoing Phase Ib clinical trial in patients with severe sepsis. The interim analysi...
Nes-Ziona, Israel, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics, Ltd., a clinical-stage immunotherapy company, today announced the appointment of Dr. Oren Hershkovitz as Chief Executive Officer, effective November 16, 2019. Dr. Hershkovitz served for nearly a decade in manageria...
Nes-Ziona, Israel, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq:ENLV), a clinical-stage immunotherapy company, today announced today that the European and Int'l Shock Societies selected, for an oral presentation, “Pathogen- and damage-associated m...
Nes-Ziona, Israel, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics, Ltd., a clinical-stage immunotherapy company, today announced that the European Patent Office granted a new patent (#EP 2 929 015 B1) covering ALLOCETRA TM , the company’s immunotherapy product. This new paten...
Nes-Ziona, Israel, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that the European Molecular Biology Organization (EMBO) selected, for a scientific presentation, the poster: “Combination Of Enliv...
Gainers: PDS Biotechnology (NASDAQ: PDSB ) +23% . The Meet Group (NASDAQ: MEET ) +20% . Synthesis Energy Systems (NASDAQ: SES ) +14% . Microbot Medical (NASDAQ: MBOT ) +19% . TuanChe (NASDAQ: TC ) +14% . Arcturus Therapeutics Holdings (NASDAQ: ARCT ) +14% . Sorrento Therapeutics (NA...
Gainers : The Stars Group (NASDAQ: TSG ) +29% . Naked Brand Group (NASDAQ: NAKD ) +15% . Yuma Energy (NYSEMKT: YUMA ) +15% . Surface Oncology (NASDAQ: SURF ) +14% . Catalyst Biosciences (NASDAQ: CBIO ) +13% . NIO (NYSE: NIO ) +13% . Zynex (NASDAQ: ZYXI ) +11% . Aimmune Therapeutics ...
This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. The Bounce/Lag...
This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc...
Nes-Ziona, Israel, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq:ENLV), a clinical-stage immunotherapy company, today announced the first presentation of its preclinical studies, which were designed to evaluate the combination of Enlivex’s Allocetra-OTS...
News, Short Squeeze, Breakout and More Instantly...
Enlivex Therapeutics Ltd. Company Name:
ENLV Stock Symbol:
NASDAQ Market:
Enlivex Therapeutics Ltd. Website:
• First study of Allocetra TM in psoriatic arthritis, a chronic inflammatory condition that causes joint pain, swelling and stiffness, affects as many as 30% of people with psoriasis 1 , and has limited treatment options Nes-Ziona, Israel, July 23, 2024 (GLOB...
ORLANDO, FL / ACCESSWIRE / July 19, 2024 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 20, at 7 p.m. Eastern T...
First patient dosed with Allocetra TM in thumb osteoarthritis, a degenerative, debilitating and progressive disease that affects millions of people Thumb osteoarthritis currently has no FDA-approved therapy and no effective long-term treatments Ness-Ziona, Israel, June 24, 2024 (GLO...